Funny shares of Magical Pharma gaining more than 14% this week. The company delivering another strong quarter as demand for its resifa, the only FDA approved mash treatment drug continues to rise. Madrical also announcing last week that it secured a global license for an oral GLP1 drug that will combine with resifra for a once a day pill.For more on the quarter and the path of path ahead, magical CEO Bill Civil joins us now. Bill, great to see you again. Great to see you, Michelle.Thanks for having me again ...